Pascal Sebastian Bailon is a notable inventor based in Florham Park, NJ (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of 8 patents. His work focuses on developing innovative conjugates that enhance the efficacy of therapeutic agents.

Latest Patents

Among his latest patents is the development of interferon conjugates, specifically a physiologically active PEG-IFNα conjugate. This invention showcases a novel formula that aims to improve the therapeutic potential of interferons. Additionally, he has introduced a new class of activated polyalkylene glycol acids and their active ester reagents. These reagents are designed for conjugation to biopharmaceuticals, including polypeptides, sugars, proteins, and therapeutically active small molecules, ultimately producing biologically active conjugates.

Career Highlights

Throughout his career, Pascal has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise in biopharmaceutical innovations.

Collaborations

Pascal has collaborated with esteemed colleagues such as Chee-Youb Won and John E. Smart. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Pascal Sebastian Bailon is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving therapeutic solutions.